Success Stories: In Less Than 3 Months, NIW Status Confirmed for a Researcher in Biomedical Science from China, Credit to Our Team of Experts

Client’s Testimonial:

“Thank you very much for your support!”

On April 1^st, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the Field of Biomedical Science (Approval Notice).

General Field: Biomedical Science

Position at the Time of Case Filing: Researcher

Country of Origin: China

Country of Residence at the Time of Filing: China

Approval Notice Date: April 1^st, 2022

Processing Time: 2 months, 28 days

Case Summary:

A researcher with a Ph.D. in medical science came to us seeking help with her NIW petition. Hailing from China, her proposed endeavor was to work on the development of disease transmission models, identification of disease-related gene loci, and performance of in-depth studies of widespread diseases such as heart disease and cancer. She wanted to provide tools and frameworks for the development of more effective disease control and prevention policies, as well as medical and clinical strategies, to improve public health and patient outcomes.

This made it clear to us that her research advancing her proposed endeavor is of great importance because it advances scientific knowledge concerning the treatment of and prevention of cardiovascular diseases (CVDs), and economic growth in the global biopharmaceutical market. This is why one of her recommenders said:

“From mechanism to new cancer and cardiovascular treatments, these industries are responsible for saving millions of lives every year, and [the client] has contributed to them through her own discoveries and developments in biomedical science. Her skills in proteomics, and biochemistry find themselves perfectly situated in these industries which are beneficial to global health, as well as the economy.”

At the same time, we noted that her research has resulted in 10 peer-reviewed journal articles (1 of them first-authored) which have been cited a total of 195 times according to Google Scholar. Furthermore, her study has received funding from the National Natural Science Foundation of China (NSFC).

She had obtained 4 letters of recommendation from other experts of which another one said the following:

“Through her numerous contributions to biomedical science, [the client] is well situated to benefit the United States’ historically robust biopharmaceutical and biomedical industries. As [the client’s] research is focused on the diseases on the genetic level, her research is critical for the development of targeted drugs for diseases, such as male infertility, as discussed above. Such expertise makes [the client] a vital asset to the United States, and I strongly urge that her work continues without interruption.”

At the same time, we showed that she has pursued research directly related to her proposed endeavor for 11 years now which granted her the opportunity to do her best in the field. This helped us obtain her NIW approval in a short period of time. We are grateful to her for choosing our firm and our team wishes her the very best.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.